Irit Starobin currently serves as the BU Head at Sandoz since May 2023, following a substantial tenure at Novartis from February 2001 to May 2023, where Irit held various roles including Sandoz Bio Manager, First Line & Product Manager in Neuroscience, and Training Manager among others. Prior experience includes working as a Medical Representative at Mediline LTD from December 1998 to February 2001. Irit's academic background includes an MBA from Edinburgh Business School, a Teaching Certification in Chemistry from Bar-Ilan University, and a BA in Chemistry, also from Bar-Ilan University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices